Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide

American Journal of Ophthalmology

Volumn 122, Issue 4, 1996, Pages 594-595

  Ip, M ^a   Gorin, M B ^a  

^a Ophthalmology and Visual Science Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; CHOROID DISEASE; DOSE RESPONSE; FEMALE; HUMAN; LASER COAGULATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0029782679     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)72131-2     Document Type: Article

References (4)

1. RC Watzke AJ Packer JC Folk WE Benson D Burgess RR. Ober Punctate inner choroidopathy Am J Ophthalmol 98 1984 572 584
2. MD Wolf JC. Folk Choroidal neovascularization in inflammatory diseases of the choroid and retina ARVO abstract. Invest Ophthalmol Vis Sci 32 4, suppl 1991 689
3. G Ehninger K Eger A Stuhler U. Schuler Thalidomide: the need for a new clinical evaluation of an old drug Bone Marrow Transplant 12 suppl 1993 S26 S28
4. RL Barnhill AC. McDougall Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions J Am Acad Dermatol 7 1982 317 323